Tocilizumab plus glucocorticoids is beneficial for patients with COVID-19 who require oxygen therapy, according to updated EULAR “points to consider” on the use of immunomodulatory therapies in SARS-CoV-2. The 2021 update also states that anti-SARS-CoV-2 monoclonal antibodies and convalescent plasma may be useful in early phases of the disease and in certain immunosuppressed patients.
WASHINGTON — Genetic testing can provide answers about children who may have primary immunodeficiencies when antibody and cell testing meet their limits, according to a…
Use of CAPTURE plus peak expiratory flow resulted in “good” sensitivity and negative predictive value for detecting patients with COPD in need of treatment, according…
Starting exercise training early in a hospitalization for a COPD exacerbation led to improved exercise capacity and physical function at discharge, according to study results…
Black Maternal Health Week is observed April 11 to 17.It is well known that the United States has a maternal health crisis — one that…
In a Healio video exclusive, Edward V. Loftus Jr., MD, noted that although some concerns remain for switching patients between interchangeable biosimilars, data has continued…
An automated algorithm designed to identify rheumatology patients who need to “shield” against COVID-19 demonstrated results that matched the “gold standard” of manual review in…
Ever since my third-year clinical rotations in medical school, I can usually predict what will be written about me in my evaluations before seeing them.…
BALTIMORE — With a global increase in natural disasters, it has become more urgent for nephrology practices to prepare facilities and patients for potential disruptions…
Although the use of computer navigation and robotic assistance yielded longer operative times in total joint arthroplasty, published results showed these methods had no association…
BOSTON — In this Healio Video Perspective from the ASCRS meeting, Arun C. Gulani, MD, founding director and chief surgeon of Gulani Vision Institute, discusses…
